Latest News

Thursday, May 05, 2016 | Product Releases, Haag Streit, Reliance Medical Products

Reliance Medical Products Launches I-OPS In-Office Procedure System at ASCRS

Reliance Medical Products and Haag-Streit USA announced the launch of the I-OPS In-Office Procedure System at the ASCRS meeting in New Orleans, according to a company news release. Developed in col…

Read the full story

Thursday, May 05, 2016 | Conferences, Abbott Medical Optics, AMO

Abbott to Host 20th Anniversary AMO University Event

On Friday, May 6, Abbott Medical Optics will host AMO University, which marks it's 20th anniversary this year. The 20th anniversary AMO University event is all about harnessing possibility to empo…

Read the full story

Thursday, May 05, 2016 | Dry Eye, Product Releases, TearScience

TearScience Introduces LipiScan for Rapid High-Definition Meibomian Imaging

TearScience, manufacturer of LipiView II and LipiFlow for the treatment of meibomian gland dysfunction (MGD), announced the release of LipiScan, the first and only dedicated high-definition gland imag…

Read the full story

Thursday, May 05, 2016 | Clinical Trials, Dry Eye, Lumenis Vision

Lumenis to Present Interim Safety and Efficacy Results of IPL with OPT for Treating Dry Eye at ASCRS

Lumenis will present interim results of a multicenter, prospective clinical trial designed to study the safety and efficacy of Optimal Pulse Technology (OPT), the next generation of Intense Pulse Ligh…

Read the full story

Thursday, May 05, 2016 | Partnerships

Refractive Surgery Alliance Society (RSA) Announces Membership in the American Refractive Surgery Council (ARSC)

Refractive Surgery Alliance Society (RSA), a professional organization comprised refractive and cataract surgeons, announced it has joined the American Refractive Surgery Council (ARSC), a worki…

Read the full story

Thursday, May 05, 2016 | Clinical Trials, Aerie Pharmaceuticals

Aerie Pharmaceuticals Completes Enrollment of Mercury 1 Phase 3 Registration Trial of Roclatan

Aerie Pharmaceuticals announced the completion of patient enrollment in the company’s initial phase 3 registration trial (Mercury 1) of Roclatan (netarsudil/latanoprost ophthalmic solution) 0.02…

Read the full story

Thursday, May 05, 2016 | Medical Studies

New Method Could Offer More Precise Treatment for Corneal Disease

Researchers have developed a new light-based technique that selectively stiffens tissue in the cornea and might one day offer improved treatment for eye problems caused by weakened corneal tissue, acc…

Read the full story

Thursday, May 05, 2016 | Earnings & Financials, TearLab Corp.

TearLab Announces $17.3 Million Public Offering

TearLab announced May 4, 2016, the pricing of a public offering of the company’s common stock, resulting in total gross proceeds of approximately $17.3 million. The offering is expected to close…

Read the full story

Thursday, May 05, 2016 | Clinical Trials, Conferences, GrayBug

Graybug Vision GB-102 Toxicology/PK Study Presented at ARVO 2016

Graybug Vision announced that a second poster with new data from a preclinical study of its lead product, GB-102, a novel injectable depot formulation containing a compound blocking VEGF and PDGF rece…

Read the full story

Thursday, May 05, 2016 | Product Releases, Imprimis Pharmaceuticals

Imprimis to Launch IV Free Conscious Sedation and New Compounded Triple Drop Formulations at ASCRS

Imprimis Pharmaceuticals announced plans to launch its IV Free MKO Melt conscious sedation formulations and new triple combination eye drop that includes nepafenac at the American Society of Cataract&…

Read the full story

Thursday, May 05, 2016 | Partnerships, Bausch+Lomb

Bausch + Lomb and IBM Collaborate on App for iPhone and iPad for Cataract Surgeons on IBM Cloud

Bausch + Lomb and IBM announced a collaboration to develop an app on the iPhone and iPad for cataract surgeons aimed at helping surgeons streamline their workflow by delivering patient information and…

Read the full story

Thursday, May 05, 2016 | Clinical Trials, American Academy of Ophthalmology

AAO: Glaucoma Drug-Dispensing Eye Insert Shows Promise as New Option for Patients Struggling to Take Daily Prescription Eye Drops

A new device that slowly releases eye medication may one day be a promising option for the many glaucoma patients who struggle with administering their own daily prescription eye drops. New research s…

Read the full story

Thursday, May 05, 2016 | Conferences, Alcon Laboratories

Alcon Highlights Upcoming Activities During ASCRS

Alcon announced its upcoming presentations, launches and events to take place during the Annual ASCRS Symposium and Congress in New Orleans, starting on May 6. Data Presentations Among the prese…

Read the full story

Thursday, May 05, 2016 | Clinical Trials

Refocus Group Completes Phase 3 Clinical Trial on the VisAbility Micro-Insert System for Presbyopia; Raises Additional Funding

Refocus Group announced it has completed the enrollment of its phase 3 clinical trial on the VisAbility Micro-Insert System for presbyopia, and secured an additional $15 million in financing from MedC…

Read the full story

Thursday, May 05, 2016 | Medical Studies, Retina, SalutarisMD

Salutaris Medical Devices Wet AMD Distance of Choroid Study Presented at ARVO

Results from the Salutaris Medical Devices wet age-related macular degeneration (AMD) Distance of Choroid Study (DOCS) were featured in two presentations at the Association for Research in Vision and …

Read the full story
Load More
 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $14.52  -8.33% 
 Akorn, Inc. $23.88  -2.05% 
 Alimera Sciences, Inc. $1.92  -13.12% 
 Allergan $210.34  -1.99% 
 Avalanche Biotechnologies $4.83  -3.21% 
 Bayer $111.75  -0.91% 
 Can-Fite Biopharma $2.60  -1.14% 
 Carl Zeiss Meditec $29.66  -0.57% 
 Cooper Companies, Inc. $153.69  0.28% 
 Eleven Biotherapeutics $1.03  -8.85% 
 Escalon Medical Corp. $0.75  -2.27% 
 Essilor International $127.50  -1.92% 
 Glaukos $23.50  -5.13% 
 Imprimis Pharmaceuticals, Inc. $3.73  6.57% 
 Inotek Pharmaceuticals $10.37  0.29% 
 InSite Vision, Inc. $0.35  0.00% 
 IRIDEX Corporation $12.12  -0.45% 
 Johnson & Johnson $112.88  0.59% 
 Luxottica Group, S.p.A. $56.01  -0.87% 
 Merck & Company, Inc. $54.09  -1.31% 
 NicOx $8.01  -3.14% 
 NovaBay Pharmaceuticals, Inc. $2.40  -7.08% 
 Novartis AG Common Stock $74.12  -0.28% 
 Ocular Therapeutix $10.52  -1.13% 
 Ophthotech Corporation $43.47  3.90% 
 QLT $1.51  -4.43% 
 Quantel $3.57  2.29% 
 Regeneron $377.73  4.74% 
 Roche $30.70  -0.97% 
 Second Sight Medical Products $4.07  -6.86% 
 Shire $175.90  -1.43% 
 STAAR Surgical Company $7.55  -1.05% 
 TearLab Corporation $0.83  1.68% 
 Thrombogenics $3.70  0.00% 
 Topcon Corporation $9.97  2.15% 
 TriVascular Technologies, Inc. $5.87  0.00% 
 Valeant Pharmaceuticals $34.49  -0.86% 
 Xoma $0.74  -3.91%